Abstract:BackgroundElastogenesis of elastic extracellular matrix (ECM) which was recognized as a major component of blood vessels has been believed for a long time to play only a passive role in the dynamic vascular changes of typical hypertension. Emilin1 gene participated in the transcription of ECM's formation and was recognized to modulate links TGF-β maturation to blood pressure homeostasis in animal study. Recently relevant advances urge further researches to investigate the role of Emilin1 gene in regulating TGF… Show more
“…In fact, recent association studies have suggested that specific haplotypes of EMILIN1 are useful genetic markers of essential hypertension in Japanese men and that the interaction of age and genotype variation of specific single nucleotide polymorphisms might increase the risk of hypertension in a northern Han Chinese population. 6,7 Here, we have addressed the question of the cellular context of Emilin-1 activity using a phenotype rescue approach by expressing the protein in either ECs or VSMCs or in all cells of the arterial wall of Emilin1 −/− mice. Our results indicate that Emilin-1 expression in VSMCs is specifically required for BP control and further clarify that the protein regulates the arteriolar myogenic response through TGF-β.…”
Objective-Emilin-1 is a protein of elastic extracellular matrix involved in blood pressure (BP) control by negatively affecting transforming growth factor (TGF)-β processing. Emilin1 null mice are hypertensive. This study investigates how Emilin-1 deals with vascular mechanisms regulating BP. Methods and Results-This study uses a phenotype rescue approach in which Emilin-1 is expressed in either endothelial cells or vascular smooth muscle cells of transgenic animals with the Emilin1 −/− background. We found that normalization of BP required Emilin-1 expression in smooth muscle cells, whereas expression of the protein in endothelial cells did not modify the hypertensive phenotype of Emilin1 −/− mice. We also explored the effect of treatment with anti-TGF-β antibodies on the hypertensive phenotype of Emilin1 −/− mice, finding that neutralization of TGF-β in Emilin1 null mice normalized BP quite rapidly (2 weeks). Finally, we evaluated the vasoconstriction response of resistance arteries to perfusion pressure and neurohumoral agents in different transgenic mouse lines. Interestingly, we found that the hypertensive phenotype was coupled with an increased arteriolar myogenic response to perfusion pressure, while the vasoconstriction induced by neurohumoral agents remained unaffected. We further elucidate that, as for the hypertensive phenotype, the increased myogenic response was attributable to increased TGF-β activity. Key Words: Emilin1 ◼ myogenic response ◼ systemic hypertension ◼ transforming growth factor ◼ vascular smooth muscle
Conclusion-Our
“…In fact, recent association studies have suggested that specific haplotypes of EMILIN1 are useful genetic markers of essential hypertension in Japanese men and that the interaction of age and genotype variation of specific single nucleotide polymorphisms might increase the risk of hypertension in a northern Han Chinese population. 6,7 Here, we have addressed the question of the cellular context of Emilin-1 activity using a phenotype rescue approach by expressing the protein in either ECs or VSMCs or in all cells of the arterial wall of Emilin1 −/− mice. Our results indicate that Emilin-1 expression in VSMCs is specifically required for BP control and further clarify that the protein regulates the arteriolar myogenic response through TGF-β.…”
Objective-Emilin-1 is a protein of elastic extracellular matrix involved in blood pressure (BP) control by negatively affecting transforming growth factor (TGF)-β processing. Emilin1 null mice are hypertensive. This study investigates how Emilin-1 deals with vascular mechanisms regulating BP. Methods and Results-This study uses a phenotype rescue approach in which Emilin-1 is expressed in either endothelial cells or vascular smooth muscle cells of transgenic animals with the Emilin1 −/− background. We found that normalization of BP required Emilin-1 expression in smooth muscle cells, whereas expression of the protein in endothelial cells did not modify the hypertensive phenotype of Emilin1 −/− mice. We also explored the effect of treatment with anti-TGF-β antibodies on the hypertensive phenotype of Emilin1 −/− mice, finding that neutralization of TGF-β in Emilin1 null mice normalized BP quite rapidly (2 weeks). Finally, we evaluated the vasoconstriction response of resistance arteries to perfusion pressure and neurohumoral agents in different transgenic mouse lines. Interestingly, we found that the hypertensive phenotype was coupled with an increased arteriolar myogenic response to perfusion pressure, while the vasoconstriction induced by neurohumoral agents remained unaffected. We further elucidate that, as for the hypertensive phenotype, the increased myogenic response was attributable to increased TGF-β activity. Key Words: Emilin1 ◼ myogenic response ◼ systemic hypertension ◼ transforming growth factor ◼ vascular smooth muscle
Conclusion-Our
“…The present study in Singaporean Chinese subjects (mean age below 50 years) observed a similar association of EH with rs2011616 (Table 3) as found in northern Han Chinese subjects aged o50 years. 28 Similarly, the Japanese study by Shimodaira et al in hypertensive patients and controls without FHH showed a genotypic association of EH with the G allele (AG/ GG genotype) of rs2011616. 15 The present study also detected an association of the G allele of rs2011616 with hypertension.…”
Section: Discussionmentioning
confidence: 90%
“…We identified rs7424556 after screening for genetic variants. Shen et al 28 and Shimodaira et al 15 might have missed rs7424556, because they selected their SNPs from public databases, such as those of the International HapMap Project and the NCBI.…”
Section: Discussionmentioning
confidence: 99%
“…The study by Shen et al showed that northern Han Chinese aged 460 years with the A allele (AG/ AA genotype) of rs2011616 had increased risk for hypertension, but persons aged o50 years had a decreased risk. 28 This discrepant allelic effect on the BP is difficult to interpret. The present study in Singaporean Chinese subjects (mean age below 50 years) observed a similar association of EH with rs2011616 (Table 3) as found in northern Han Chinese subjects aged o50 years.…”
Studies in mice suggest that the elastin microfibril interfacer-1 gene (EMILIN1), the gene encoding elastin microfibril interfacer-1 protein, contributes to the pathogenesis of essential hypertension (EH) in humans. EMILIN1 in part maintains elastic fibres in vessel walls, and hence peripheral arterial compliance. In a case-control study, we assessed 942 non-obese non-diabetic Chinese, comprising 467 patients with EH and 475 normotensive control subjects (166 without, and 309 with, family history of hypertension in first-degree relatives (FHH)). Hypertension in first-degree relatives occurred in 88%, 65% and 0% of cases, all controls and controls without FHH, respectively. We scanned for single-nucleotide polymorphisms (SNPs) and genotyped them in the EMILIN1 gene using high-resolution melt-curve analysis. No exonic variants were detected. We assessed the association of SNPs and their haplotypes with EH. Three SNPs in introns 1 and 5 (rs2289360, rs2011616 and rs7424556) were in strong pair-wise linkage disequilibrium (r(2)>0.89). All three SNPs were significantly associated with hypertension. Genotypic frequencies at the three SNPs differed significantly between cases and only those controls without FHH. Healthy controls with FHH should be excluded to increase the odds of detecting association. All the G alleles of rs2289360 (odds ratio = 1.69, P = 0.010), rs2011616 (odds ratio = 1.52, P = 0.038) and rs7424556 (odds ratio = 1.59, P = 0.023) were high-risk alleles in the recessive genetic model. We observed significant overall haplotypic association with EH (empirical P = 0.0072); GGG is a risk haplotype (P = 0.043). The overall results support EMILIN1 as a candidate gene for human EH.
“…Recently, several genes were reported to be involved in blood pressure regulation and the susceptibility to hypertension modulated by age (Dao et al, 2005;Lunetta et al, 2007;Shen et al, 2009;Shi et al, 2009). Furthermore, the statistical analysis strategy of age-genetic effects can prevent potential confounding bias modified by age-varying characteristics (Lunetta et al, 2007;Lasky-Su et al, 2008;Percy et al, 2009).…”
Our data suggests that age might modulate the genetic effects of variation of rs204994 in AGER on HT and further replications in other populations and functional studies should be warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.